new glp 1 agonist How GLP-1 medications are transforming diabetes and weight loss treatment GLP-1 Receptor Agonists as Treatments

KruskalWallis test, p-value=0.016)

Walker, S

Additionally, evaluating the long-term use of GLP-1RA, particularly across different populations, could provide valuable insights into its therapeutic potential and risk profile, which will contribute to developing more effective treatment strategies and improving the prognosis and quality of life for patients with ischemic stroke and diabetes (128, 129)

Mol Metab (2021) 47:101180

For studies with measurements of plasma insulin and glucagon concentrations, plasma was collected by tail vein bleeding at timepoints 0, 60, 120 and 240 min

Though these drugs have been deemed effective in treating T2DM, the Food and Drug Administration (FDA) and some members of the scientific community have questioned the safety of these therapeutics relative to important cardiovascular endpoints